KIMBERLY HAGEDORN: Open Payments
NPI 1669832556 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 39 payments from 20 companies in 2025. Trend: 2023 $845 · 2024 $529 · 2025 $1,339
Food & beverage: $1,131Education: $208
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $280 |
| Incyte Corporation | 3 | $241 |
| Tempus AI, Inc | 2 | $137 |
| AstraZeneca Pharmaceuticals LP | 3 | $128 |
| Janssen Biotech, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| EMD Serono, Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| GENZYME CORPORATION | 2 | $31 |
Products named: OPDIVO, JAKAFI, XT CDX, RYBREVANT, IMFINZI, LUTATHERA, ENHERTU, KISQALI.
Industry payments across MO — which companies pay providers there.
